Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 13.7B | 11.7B | 10.0B | 11.1B |
Cost of revenue | 5.6B | 5.7B | 5.1B | 5.0B |
Gross profit | 8.1B | 6.0B | 4.9B | 6.2B |
Operating expense | ||||
Research & development | 1.5B | 1.7B | 1.6B | 1.5B |
Selling general and admin | 3.7B | 4.3B | 3.7B | 4.1B |
Other operating expenses | 829M | -3.9B | 3.7B | 599M |
Operating income | 2.3B | 3.5B | -3.8B | 525M |
Non operating interest income | ||||
Income | 92M | 114M | 150M | 95M |
Expense | 584M | 385M | 642M | 682M |
Other income expense | — | — | — | — |
Pretax income | 1.8B | -481M | -4.3B | -97M |
Tax provision | 526M | -153M | -153M | -71M |
Net income | 1.3B | -328M | -4.2B | -26M |
Basic EPS | 1.3 | — | -4.3 | 0.0 |
Diluted EPS | 1.3 | — | -4.3 | 0.0 |
Basic average shares | 982.4M | — | 982.4M | 982.4M |
Diluted average shares | 982.4M | — | 982.4M | 982.4M |
EBITDA | 3.6B | 1.7B | 1.1B | 1.7B |
Net income from continuing op. | 1.3B | -328M | -4.2B | -26M |
Minority interests | -5M | -7M | 11M | -8M |
Preferred stock dividends | 0 | 0 | 0 | 0 |